199 related articles for article (PubMed ID: 22025930)
1. Ovarian cancer: diagnosis and treatment.
Burges A; Schmalfeldt B
Dtsch Arztebl Int; 2011 Sep; 108(38):635-41. PubMed ID: 22025930
[TBL] [Abstract][Full Text] [Related]
2. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.
Lavoue V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lecuru F; Lefrere-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Senechal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():214-223. PubMed ID: 30905627
[TBL] [Abstract][Full Text] [Related]
3. [Third National Ovarian Consensus. 2011. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México "GICOM"].
Gallardo-Rincón D; Cantú-de-León D; Alanís-López P; Alvarez-Avitia MA; Bañuelos-Flores J; Herbert-Núñez GS; Oñate-Ocaña LF; Pérez-Montiel MD; Rodríguez-Trejo A; Ruvalcaba-Limón E; Serrano-Olvera A; Ortega-Rojo A; Cortés-Esteban P; Erazo-Valle A; Gerson-Cwilich R; De-la-Garza-Salazar J; Green-Renner D; León-Rodríguez E; Morales-Vásquez F; Poveda-Velasco A; Aguilar-Ponce JL; Alva-López LF; Alvarado-Aguilar S; Alvarado-Cabrero I; Aquino-Mendoza CA; Aranda-Flores CE; Bandera-Delgado A; Barragán-Curiel E; Barrón-Rodríguez P; Brom-Valladares R; Cabrera-Galeana PA; Calderillo-Ruiz G; Camacho-Gutiérrez S; Capdeville-García D; Cárdenas-Sánchez J; Carlón-Zárate E; Carrillo-Garibaldi O; Castorena-Roji G; Cervantes-Sánchez G; Coronel-Martínez JA; Chanona-Vilchis JG; Díaz-Hernández V; Escudero-de-los Ríos P; Garibay-Cerdenares O; Gómez-García E; Herrera-Montalvo LA; Hinojosa-García LM; Isla-Ortiz D; Jiménez-López J; Lavín-Lozano AJ; Limón-Rodriguez JA; López-Basave HN; López-García SC; Maffuz-Aziz A; Martínez-Cedillo J; Martínez-López DM; Medina-Castro JM; Melo-Martínez C; Méndez-Herrera C; Montalvo-Esquivel G; Morales-Palomares MA; Morán-Mendoza A; Morgan-Villela G; Mota-García A; Muñoz-González DE; Ochoa-Carrillo FJ; Pérez-Amador M; Recinos-Money E; Rivera-Rivera S; Robles Flores JU; Rojas-Castillo E; Rojas-Marín C; Salas-Gonzáles E; Sámano-Nateras L; Santibañez-Andrade M; Santillán-Gómez A; Silva-García A; Silva JA; Solorza-Luna G; Tabarez-Ortiz AR; Talamás-Rohana P; Tirado-Gómez LL; Torres-Lobatón A; Quijano-Castro F
Rev Invest Clin; 2011; 63(6):665-702. PubMed ID: 23650680
[TBL] [Abstract][Full Text] [Related]
4. [Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Bolze PA; Collinet P; Golfier F; Bourgin C
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):168-179. PubMed ID: 30686727
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study.
Spiliotis J; Halkia E; Lianos E; Kalantzi N; Grivas A; Efstathiou E; Giassas S
Ann Surg Oncol; 2015 May; 22(5):1570-5. PubMed ID: 25391263
[TBL] [Abstract][Full Text] [Related]
6. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
Rosendahl M; Høgdall CK; Mosgaard BJ
Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
[TBL] [Abstract][Full Text] [Related]
7. Recognizing and treating ovarian cancer.
Gostout BS; Pachman DR; Lechner R
Minn Med; 2012 Mar; 95(3):40-2. PubMed ID: 22611819
[TBL] [Abstract][Full Text] [Related]
8. Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study.
Olawaiye AB; Java JJ; Krivak TC; Friedlander M; Mutch DG; Glaser G; Geller M; O'Malley DM; Wenham RM; Lee RB; Bodurka DC; Herzog TJ; Bookman MA
Gynecol Oncol; 2018 Oct; 151(1):18-23. PubMed ID: 30135020
[TBL] [Abstract][Full Text] [Related]
9. A systematic overview of chemotherapy effects in ovarian cancer.
Högberg T; Glimelius B; Nygren P;
Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
[TBL] [Abstract][Full Text] [Related]
10. Is laparotomy for staging early ovarian cancer an absolute necessity?
Possover M; Mader M; Zielinski J; Pietrzak K; Hettenbach A
J Am Assoc Gynecol Laparosc; 1995 May; 2(3):285-8. PubMed ID: 9050572
[TBL] [Abstract][Full Text] [Related]
11. Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.
García-Sáenz JA; Custodio A; Casado A; Vidart JA; Coronado PJ; Martín M; López-Tarruella S; Puente J; Fernández C; Díaz-Rubio E
Clin Transl Oncol; 2011 Feb; 13(2):121-32. PubMed ID: 21324801
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Vergote I; Coens C; Nankivell M; Kristensen GB; Parmar MKB; Ehlen T; Jayson GC; Johnson N; Swart AM; Verheijen R; McCluggage WG; Perren T; Panici PB; Kenter G; Casado A; Mendiola C; Stuart G; Reed NS; Kehoe S; ;
Lancet Oncol; 2018 Dec; 19(12):1680-1687. PubMed ID: 30413383
[TBL] [Abstract][Full Text] [Related]
13. Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
du Bois A; Kristensen G; Ray-Coquard I; Reuss A; Pignata S; Colombo N; Denison U; Vergote I; Del Campo JM; Ottevanger P; Heubner M; Minarik T; Sevin E; de Gregorio N; Bidziński M; Pfisterer J; Malander S; Hilpert F; Mirza MR; Scambia G; Meier W; Nicoletto MO; Bjørge L; Lortholary A; Sailer MO; Merger M; Harter P;
Lancet Oncol; 2016 Jan; 17(1):78-89. PubMed ID: 26590673
[TBL] [Abstract][Full Text] [Related]
14. The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity score.
Foster JM; Sleightholm R; Smith L; Ceelen W; Deraco M; Yildirim Y; Levine E; Muñoz-Casares C; Glehen O; Patel A; Esquivel J
J Surg Oncol; 2016 Dec; 114(7):779-784. PubMed ID: 27792292
[TBL] [Abstract][Full Text] [Related]
15. [Clinical recommendations for diagnosing, treatment and monitoring of patients with ovarian cancer -- Croatian Oncology Society and Croatian Society for Gynecology and Obstetrics as Croatian Medical Association units and Croatian Society of Gynecological Oncology].
Matković V; Haller H; Vrdoljak E; Corusić A; Jelavić TB; Strinić T; Karnjus-Begonja R; Barisic D; Tomić S; Kukura V; Ban M; Ranka SP; Matic M; Skalec SL; Topolovec Z; Mrcela M; Zekan J; Fröbe A; Hajredini A; Babic D; Mamula O; Brncić-Fischer A; Vojnović Z; Sundov D; ; ;
Lijec Vjesn; 2013; 135(9-10):235-41. PubMed ID: 24364199
[TBL] [Abstract][Full Text] [Related]
16. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Oza AM; Cook AD; Pfisterer J; Embleton A; Ledermann JA; Pujade-Lauraine E; Kristensen G; Carey MS; Beale P; Cervantes A; Park-Simon TW; Rustin G; Joly F; Mirza MR; Plante M; Quinn M; Poveda A; Jayson GC; Stark D; Swart AM; Farrelly L; Kaplan R; Parmar MK; Perren TJ;
Lancet Oncol; 2015 Aug; 16(8):928-36. PubMed ID: 26115797
[TBL] [Abstract][Full Text] [Related]
17. Ultra-radical upfront surgery does not improve survival in women with advanced epithelial ovarian cancer; a natural experiment in a complete population.
Falconer H; Joneborg U; Krawiec K; Palsdottir K; Bottai M; Salehi S
Gynecol Oncol; 2020 Oct; 159(1):58-65. PubMed ID: 32712154
[TBL] [Abstract][Full Text] [Related]
18. Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome.
Gao B; Lindemann K; Anderson L; Fereday S; Hung J; Alsop K; Tothill RW; Gebski V; Kennedy C; Balleine RL; ; Harnett PR; Bowtell DD; DeFazio A
Gynecol Oncol; 2016 Sep; 142(3):458-64. PubMed ID: 27444035
[TBL] [Abstract][Full Text] [Related]
19. The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum.
Zivanovic O; Sima CS; Iasonos A; Hoskins WJ; Pingle PR; Leitao MM; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
Gynecol Oncol; 2010 Mar; 116(3):351-7. PubMed ID: 20022092
[TBL] [Abstract][Full Text] [Related]
20. [Long-term survival metastatic ovarian cancer elderly patient].
Amoroso L; De Iuliis F; Taglieri L; Vendittozzi S; Salerno G; Blasi L; Lanza R
Clin Ter; 2014; 165(6):305-8. PubMed ID: 25524187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
